The differential diagnosis of primary ADHD should be aware that a child arises out of complexity in the development of the curriculum due to cognitive disfunction, logical and abstract thinking is complicated. Diagnosis of ADHD involves the use of a wide range of experimental psychological and instrumental tests, the main of which are given in this article. Treatment of patients with ADHD include psycho-pedagogical correction in patients with mild ADHD to moderate forms of drug therapy, the use of various trainings aimed at improving cognitive functions, classes with a speech therapist and a neuropsychologist. Also in this article represented the results are based on a "audiogram" CT and MRI and functional MRI are listed according to the literature respectively, and drug therapy of patients with ADHD.
Alekseeva T.G., Zykov V.P., Zakharov I.B. and others. The first skrinnin neuropsychological evaluation of children and adolescents in Moscow. Neuroimmunology 2003; 1: 3: 52-55.
Zavadenko N.N., Petruhin A.S. et al. Treatment of hyperactivity with a deficit of attention in children: evaluation of the effectiveness of various methods of pharmacotherapy. Breast cancer in 1998; 19-25.
Zavadenko N.N. Attention deficit hyperactivity disorder in children: diagnostic and treatment. Breast cancer in 2006; 1: 51-56.
Zykov V.P., Begasheva O.I. Cognitive impairment in patients with tiks governmental disorders and their correction encephabol. Journal nevrol psihiat and 2003; 103; 11: 10-15.
Musatov N.M. Pantokaltsin in the treatment of hyperactivity and attention deficit. Difficult patients in 2006; 4: 6: 2-3
Nyukikten Ch. Children's Behavioral Neuroscience. Trans. from English. 2 vol. M: Terevinf 2010; 336.
Perederiy E.E. Features of psychosomatic status of a seven-year school, preterm. Psychoneurology 1999; 6: 23-29.
Sotnikova N., Gromova O.A. Immunological disorders in children with attention deficit hyperactivity disorder and their correction of the. Proceedings of the VIII International Congress on immunoreabili- tation "Allergy, Immunology, and a global network." M 2002; 96-97.
Tumashenko AF Efficiency pantokaltsina in the treatment of attention deficit hyperactivity disorder in children and adolescents. Consilium medium. Pediatrics 2006; 2: 56-58.
Barkley R. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatmen, 2nd ed. New York: Guilford Press 1996; 396.
Barkley R. Behavioral inhibition, sustained attention and executive func- tion: constructing a unified theory of ADHD. Psychol Bull 1997; 121: 65— 94.
Baumgardner T., Singer H., Denckla M. et al. Corpus callosum morphology in children with Tourette’s syndrome and attention-deficit hyperactivity disorder. Neurology 1996; 47: 55.
Bhatia M., Nigam V., Bohra N. et al. Attention deficit disorder with hyperac- tivity among paediatric outpatients. J Child Psychol Psychiatry 1991; 32: 297—306.
Biederman J., Gastfriend D., Jellinek M. Desipramine in the treatment of children with attention deficit disorder. J Clin Psychopharmacol 1986; 6: 359—363.
Conners C., Wells K., Parker J. et al. A new self-report scale for assessment of adolescent psychopathology: factor structure, reliability, validity, and diagnostic sensitivity. J Abnorm Child Psychol 1997; 25: 6: 487—497.
Cook E., Stein M., Krasowski M. et al. Association of attention-deficit disor- der and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993— 998.
Denckia M. ADHD: current concepts and neurobiology.Brain Dev. Con- gress of ICNA and AOCNA. J Br Develop 2002; 24: 336.
Diagnostical and statistical manual of mental disorders. Wachington:Am. Pssychiat Ass 1987; 567.
Epstein J., Conners C., Erhardt D. et al. Familial aggregation of ADHD characteristics. J Abnorm Child Psychol 2000; 28: 595—599.
Faraone S., Biederman J., Milberger S. An exploratory study of ADHD among second-degree relatives of ADHD children. Biol Psychiatry 1994; 35: 398—402.
Gammon G., Brown T. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 1993; 3: 1—10.
Harter M., Annelo-Vento L., Wood F. et al. Separate brain potential charac- teristics in children with reading disability and attention deficit disorder. Brain Cogn 1988; 7: 115—140.
Kratochvil C., Heiligenstein J., Dittmann R. et al. Atomoxetine and meth- ylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J. Am Acad Child Adolescent Psychiatry 2002; 41: 776— 784.
LaHoste G., Swanson J., Wigal S. et al. Dopamine D4 receptor gene poly- morphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1: 121—124.
Matochik J., Liebenauer L., King A. et al. Cerebral glucose metabolism in adults with attention-deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry 1994; 151: 658—664
Menkes J. Child Neurology. 2nd ed. New York: Guilford Press 2007; 1156. Popper C. Antidepressants in the treatment of attention-deficit hyperactivity disorder. J Clin Psychiatry 1997; 58: 14—29.
Wasserman R., Kelleher K., Bocian A. et al. Identification of attentional and hyperactivity problems in primary care: a report from pediatric research in office settings and the ambulatory sentinel practice network. Pediatrics 1999; 103: 138—142.
Weinberg W., Brumback R. Primary disorder of vigilance: a novel explana- tion of inattentiveness, daydreaming, boredom, restlessness, and sleepiness. J Pediatr 1990; 116: 5: 720—725.
Zametkin A., Liebenauer L., Fitzgerald G. et al. Brain metabolism in teenag- ers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993; 50: 333—340.